Creative Medical Technology Holdings (CELZ) Long-Term Debt Repayments (2018 - 2021)
Creative Medical Technology Holdings (CELZ) posted quarterly Long-Term Debt Repayments of $506498.0 for Q3 2021, up 630.88% quarter-over-quarter from $69300.0 in Q4 2019.
Creative Medical Technology Holdings (CELZ) Long-Term Debt Repayments (2018 - 2021) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Long-Term Debt Repayments for 3 consecutive years, with $506498.0 the latest figure, recorded in Q3 2021.
- In Q3 2021, Long-Term Debt Repayments changed N/A year-over-year to $506498.0; the TTM figure through Dec 2022 stood at $506498.0 (down 12.04% YoY), while the FY2021 annual figure was $705405.0, changed N/A from the prior year.
- Long-Term Debt Repayments grew to $506498.0 in Q3 2021 per CELZ's latest filing, from $69300.0 in the prior quarter.
- Across five years, Long-Term Debt Repayments topped out at $506498.0 in Q3 2021 and bottomed at $25811.0 in Q3 2019.
- Historically, Long-Term Debt Repayments has averaged $195867.2 across 3 years, with a median of $179050.0 in 2018.
- On a YoY basis, Long-Term Debt Repayments climbed as much as 88.02% in 2019 and fell as far as 88.02% in 2019.
- Creative Medical Technology Holdings' Long-Term Debt Repayments stood at $215494.0 in 2018, then tumbled by 67.84% to $69300.0 in 2019, then soared by 630.88% to $506498.0 in 2021.
- Business Quant data shows CELZ's Long-Term Debt Repayments at $506498.0 in Q3 2021, $69300.0 in Q4 2019, and $25811.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 17.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -10.01 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Creative Medical Technology Holdings | 1.88 Mn | 1.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 506,498.00 |
| Sep 30, 2021 | 506,498.00 |
| Dec 31, 2019 | 69,300.00 |
| Dec 31, 2019 | 69,300.00 |
| Sep 30, 2019 | 25,811.00 |
| Sep 30, 2019 | 25,811.00 |
| Mar 31, 2019 | 168,300.00 |
| Mar 31, 2019 | 168,300.00 |
| Sep 30, 2018 | 215,494.00 |
| Sep 30, 2018 | 215,494.00 |
| Jun 30, 2018 | 189,800.00 |
| Jun 30, 2018 | 189,800.00 |